Compounds > 5-deaza-5,6,7,8-tetrahydrofolic acid
Page last updated: 2024-10-15
5-deaza-5,6,7,8-tetrahydrofolic acid
Description
5-deaza-5,6,7,8-tetrahydrofolic acid: RN given refers to (6R)-isomer; RN for cpd without isomeric designation not available 8/89; RN & structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 135625342 |
MeSH ID | M0167182 |
Synonyms (7)
Synonym |
l-glutamic acid, n-(4-(((2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)methyl)amino)benzoyl)-, (r)- |
115587-73-0 |
5-deaza-thf |
5-deaza-5,6,7,8-tetrahydrofolic acid |
(2s)-2-[[4-[[(6r)-2-amino-4-oxo-5,6,7,8-tetrahydro-1h-pyrido[2,3-d]pyrimidin-6-yl]methylamino]benzoyl]amino]pentanedioic acid |
DTXSID80151140 |
(2s)-2-[[4-[[(6r)-2-amino-4-oxo-5,6,7,8-tetrahydro-3h-pyrido[2,3-d]pyrimidin-6-yl]methylamino]benzoyl]amino]pentanedioic acid |
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 4 (66.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |